Option chain shows key data for Avenue Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Avenue Therapeutics.

Avenue Therapeutics (OTC:ATXI) Stock, Option Chain

Avenue Therapeutics

Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases. Its current product candidates include AJ201 for the treatment of spinal and bulbar muscular atrophy (SBMA, also known as Kennedy's Disease), intravenous tramadol (IV tramadol) for the treatment of post-operative acute pain, and BAER-101 for the treatment of epilepsy and panic disorders.

Why It Matters:

Earnings

Equities

News

Eurozone

Commodities

Markets

Trading Ideas

ADTX

AGMH

ANTE

ATXI

SYRS

Dow Dips Over 200 Points; US Industrial Production Increases More than Expected

Market Impact And Global Democracy

Pre-Market Outlook

Movers

ARBE

ARLO

Bakkt Holdings, Inc. Class A Common Stock

BKKT

FINV

GNPX

GRAB

HNRG

HROW

HYPR

KTCC

VRPX

VSTM

Why Harrow Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket

movers image

AIXI

DPRO

ELAB

GLPG

MIRA

OKYO

PMNT

RNLX

SPRC

STEC

SVMH

TCJH

TLIS

TRSG

TVGN

Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc.

Avenue Therapeutics Inc

Press Releases

Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)

Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Avenue Therapeutics to Participate in Upcoming Investor Conferences

Avenue Therapeutics to Participate in Maxim Group's 2024 Healthcare Virtual Summit

Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

Comments

Avenue Therapeutics

Avenue Therapeutics (ATXI) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell